Remote Monitoring of Patients With Hematologic Malignancies at High Risk of Febrile Neutropenia: Exploratory Study

被引:2
|
作者
Kroloff, Maxwell [1 ,2 ]
Ramezani, Ramin [2 ,3 ]
Wilhalme, Holly [4 ]
Naeim, Arash [1 ,2 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Jonsson Comprehens Canc Ctr, 10911 Weyburn Ave,Suite 300, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, Ctr Smart Hlth, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA
[4] Univ Calif Los Angeles, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90024 USA
关键词
remote monitoring; febrile neutropenia; temperature; heart rate; oxygen saturation; mobile health; mHealth; hematologic malignancies; hematology; malignancies; digital health; clinical outcomes; CANCER;
D O I
10.2196/33265
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Febrile neutropenia is one of the most common oncologic emergencies and is associated with significant, preventable morbidity and mortality. Most patients who experience a febrile neutropenia episode are hospitalized, resulting in significant economic cost. Objective: This exploratory study implemented a remote monitoring system comprising a digital infrared thermometer and a pulse oximeter with the capability to notify providers in real time of abnormalities in vital signs that could suggest early clinical deterioration and thereby improve clinical outcomes. Methods: The remote monitoring system was implemented and compared to standard-of-care vital signs monitoring in hospitalized patients with underlying hematologic malignancies complicated by a febrile neutropenia episode in order to assess the feasibility and validity of the system. Statistical analysis was performed using the intraclass correlation coefficient (ICC) to assess the consistency between the measurements taken using traditional methods and those taken with the remote monitoring system for each of the vital sign parameters (temperature, heart rate, and oxygen saturation). A linear mixed-effects model with a random subject effect was used to estimate the variance components. Bland-Altman plots were created for the parameters to further delineate the direction of any occurring bias. Results: A total of 23 patients were enrolled in the study (mean age 56, SD 23-75 years; male patients: n=11, 47.8%). ICC analysis confirmed the high repeatability and accuracy of the heart rate assessment (ICC=0.856), acting as a supplement to remote temperature assessment. While the sensitivity and specificity for capturing tachycardia above a rate of 100 bpm were excellent (88% and 97%, respectively), the sensitivity of the remote monitoring system in capturing temperatures >37.8 degrees C and oxygen saturation <92% was 45% and 50%, respectively. Conclusions: Overall, this novel approach using temperature, heart rate, and oxygen saturation assessments successfully provided real-time, clinically valuable feedback to providers. While temperature and oxygen saturation assessments lagged in terms of sensitivity compared to a standard in-hospital system, the heart rate assessment provided highly accurate complementary data. As a whole, the system provided additional information that can be applied to a clinically vulnerable population. By transitioning its application to high-risk patients in the outpatient setting, this system can help prevent additional use of health care services through early provider intervention and potentially improve outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Febrile Neutropenia in Hematologic Malignancies
    Michael K. Keng
    Mikkael A. Sekeres
    [J]. Current Hematologic Malignancy Reports, 2013, 8 : 370 - 378
  • [2] Febrile Neutropenia in Hematologic Malignancies
    Keng, Michael K.
    Sekeres, Mikkael A.
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (04) : 370 - 378
  • [3] Utilization of cefepime therapeutic drug monitoring in febrile neutropenia patients with hematologic malignancies
    Lodl, Emma F.
    Alshaer, Mohammad H.
    Adams, C. Brooke
    Richards, Ashley
    Peloquin, Charles
    Venugopalan, Veena
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023,
  • [4] Prospective Study Of An Emergency Department Febrile Neutropenia Pathway In Patients With Hematologic Malignancies
    Keng, Michael K.
    Thallner, Elaine
    Elson, Paul
    Zayac, Christine
    Sekeres, Jennifer
    Wenzell, Candice M.
    Gallagher, Erika M.
    Weber, Catherine M.
    Earl, Marc A.
    Mukherjee, Sudipto
    Seastone, David J.
    Pohlman, Brad
    Cober, Eric
    Rodgers, Beth
    Foster, Virginia B.
    Yuhas, Joy
    Kalaycio, Matt
    Bolwell, Brian J.
    Sekeres, Mikkael A.
    [J]. BLOOD, 2013, 122 (21)
  • [5] Approach to febrile neutropenia in patients undergoing treatments for hematologic malignancies
    Stohs, Erica J.
    Abbas, Anum
    Freifeld, Alison
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (02)
  • [6] FACTORS AFFECTING THE OUTCOME OF FEBRILE NEUTROPENIA IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    Zawam, H.
    Edesa, W.
    Salama, R.
    Gaber, M.
    Sherief, M.
    Naseef, C.
    Ezzat, N.
    [J]. HAEMATOLOGICA, 2015, 100 : 475 - 475
  • [7] Cefpirome as empirical treatment for febrile neutropenia in patients with hematologic malignancies
    Timmers, Gert Jan
    van Vuurden, Dannis G.
    Swart, Eleonora L.
    Simoons-Smit, Alberdina M.
    Huijgens, Peter C.
    [J]. HAEMATOLOGICA, 2005, 90 (07) : 1005 - 1006
  • [8] Risk Assessment of Adult Patients with Febrile Neutropenia and Malignancies
    Alejandria, Marissa M.
    Jamias, Jade
    Ecarma, Raquel
    Zoleta, Loreta
    Mendoza, Myrna
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S106 - S106
  • [9] Clinical Efficacy and Safety of Arbekacin against Pneumonia in Febrile Neutropenia: A Retrospective Study in Patients with Hematologic Malignancies
    Ohashi, Takashi
    Fujita, Yukiyoshi
    Irisawa, Hiroyuki
    Nakaminami, Hidemasa
    Arai, Takahiro
    Takahashi, Masumi
    Momiyama, Emi
    Murata, Naoya
    Murayama, Kayoko
    Saito, Taeko
    [J]. INFECTION AND CHEMOTHERAPY, 2022, 54 (01): : 80 - 90
  • [10] Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia
    Corrado Girmenia
    Eleonora Russo
    Ida Carmosino
    Massimo Breccia
    Francesco Dragoni
    Roberto Latagliata
    Sergio Mecarocci
    Salvatore Giacomo Morano
    Caterina Stefanizzi
    Giuliana Alimena
    [J]. Annals of Hematology, 2007, 86 : 263 - 270